Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...
MedPage Today on MSN
Targeted Duo Wins Again in BRAF-Mutant Colorectal Cancer
SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...
Company closed $22M financing to support randomized Phase 2b trial; IND cleared and study initiated; Interim results anticipated in late 2026; topline data expected in H2/2027 ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
Managing Pain and Discomfort While Deciding on a Course of Treatment Medically reviewed by Archana Sharma, DO Stage 4 colon cancer, also known as metastatic colon cancer, is an advanced cancer that ...
Preliminary results of fruquintinib in combination with FOLFIRI as second-line treatment for RAS-mutant metastatic colorectal cancer: A prospective, single-center phase 2 study. Efficacy and safety of ...
Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback